Effect of gliclazide modified release on adiponectin, interleukin-6, and tumor necrosis factor-alpha plasma levels in individuals with type 2 diabetes mellitus. (Q51488349)
Jump to navigation
Jump to search
scientific article published in October 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of gliclazide modified release on adiponectin, interleukin-6, and tumor necrosis factor-alpha plasma levels in individuals with type 2 diabetes mellitus. |
scientific article published in October 2006 |
Statements
Effect of gliclazide modified release on adiponectin, interleukin-6, and tumor necrosis factor-alpha plasma levels in individuals with type 2 diabetes mellitus. (English)
Jozef Drzewoski
1 reference
Monika Zurawska-Klis
1 October 2006
1921-1926